Detalles de la búsqueda
1.
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial.
Lancet Oncol
; 24(12): 1321-1333, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37949086
Resultados
1 -
1
de 1
1
Próxima >
>>